- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Multiple Myeloma
Total 14090 results
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
NanoAlvandCompletedMultiple Myeloma, Refractory
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
MiNK TherapeuticsCompletedRelapsed/Refractory Multiple MyelomaUnited States
-
AbbVieActive, not recruiting
-
Sun Yat-sen UniversityUnknownRelapsed, Refractory, Multiple MyelomaChina
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
University of PennsylvaniaRecruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM)United States
-
Roswell Park Cancer InstituteRecruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Nanjing Leads Biolabs Co.,LtdRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Chunrui LiInnovent Biologics (Suzhou) Co. Ltd.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of WashingtonRecruitingMultiple Myeloma | Refractory Multiple MyelomaUnited States
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, United Kingdom, Canada, Brazil, New Zealand
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
Mayo ClinicWithdrawnMultiple Myeloma | Refractory Multiple Myeloma
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
Swiss Group for Clinical Cancer ResearchTerminatedRefractory Multiple MyelomaSwitzerland
-
Genesis Pharma S.A.CompletedRelapse/Refractory Multiple MyelomaGreece
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Allarity TherapeuticsMedical Prognosis Institute A/S; Smerud Medical Research International ASTerminatedRelapsed/Refractory Multiple MyelomaDenmark
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Italy
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
University of WuerzburgCompletedRefractory Multiple Myeloma | RelapseGermany
-
BeBetter Med IncCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Non-Hodgkin's LymphomaChina
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)Spain, France
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Australia, Israel, Spain, United Kingdom, Poland, Taiwan, Singapore, France, Canada, Italy
-
Zhejiang ACEA Pharmaceutical Co. Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina